Join the 'Migraine' group to help and get support from people like you.

Migraine Blog

Related terms: Migraine Headache, Hemiplegic Migraine, Complicated Migraine, Basilar-Type Migraine, Basilar Artery Migraine

Surgery Doubted as a Migraine Reliever

Posted 29 Jun 2014 by Drugs.com

FRIDAY, June 27, 2014 – Migraine surgery is increasingly touted as a potential "cure" for the debilitating headaches, but researchers say the evidence just isn't there to support those claims. In an analysis of two studies on migraine trigger "deactivation" surgery, researchers found multiple flaws in the study methods. What's more, they say, the surgery carries risks and high costs not covered by insurance, and doesn't jibe with what's known about the underlying causes of migraine. "The surgery is, first of all, unproven. Second, permanent side effects are not uncommon," said Dr. Paul Mathew, a neurologist and headache specialist at Brigham and Women's Hospital in Boston. Those lingering problems include persistent itching and numbness in areas affected by the surgery – which is typically offered by plastic surgeons, not headache specialists. Mathew, who led the research analysis, ... Read more

Related support groups: Migraine

Chronic Migraines Affect the Whole Family

Posted 28 Jun 2014 by Drugs.com

THURSDAY, June 26, 2014 – When a spouse, partner or parent has chronic migraines, the whole family suffers, a new study found. The research discovered that most chronic migraine sufferers report that their severe headaches have a big impact on family relationships, activities and sexual intimacy. The results were not surprising to lead study author Dawn Buse, a clinical psychologist and director of behavioral medicine at Montefiore Headache Center in New York City. "I hear firsthand about the tragic effect that chronic migraine has on every aspect of people's lives, including work and home life." Still, Buse wanted to quantify the degree to which families were affected. People who don't experience migraines or have family members with the condition don't understand how it can affect the entire family, Buse said. "It's very important to bring this data to light, to show that chronic ... Read more

Related support groups: Migraine

Migraines May Worsen During Menopause

Posted 24 Jun 2014 by Drugs.com

TUESDAY, June 24, 2014 – New research confirms what women with migraine headaches have told their doctors for years: migraine attacks seem to get worse in the years before and during menopause. "In women who have migraine, headaches increase by 50 to 60 percent when they go through the perimenopause and menopausal time periods," said Dr. Vincent Martin, professor of medicine and co-director of the Headache and Facial Pain Program at the University of Cincinnati. The new finding, Martin said, "basically confirms what women have been telling us physicians for decades. We finally have some evidence." The perimenopausal period is the time when the body is transitioning to menopause – when monthly periods end. Perimenopause can last several years, and is often marked by irregular periods, hot flashes and sleep problems. Perimenopause can begin in the 40s, and menopause occurs, on average, ... Read more

Related support groups: Migraine, Menopausal Disorders

Head Injuries Tied to Higher Migraine Risk for Veterans

Posted 19 Jun 2014 by Drugs.com

THURSDAY, June 19, 2014 – U.S. veterans of the Iraq and Afghanistan wars who suffered brain injuries are at a much higher risk for headaches, especially migraines, a new study finds. Deployment-linked traumatic brain injury "is associated with a strong and highly significant increase in frequency and intensity of headache, the majority of which are migraine," concludes a team led by Dr. James Couch, of the University of Oklahoma Medical School in Oklahoma City. Couch's team noted that traumatic brain injury is the "signature injury" for U.S. troops deployed in the conflicts in Iraq and Afghanistan, "occurring in 15 percent to 20 percent of deployed soldiers." They added that "combat zone deployment, by itself, is stressful. Both traumatic brain injury and stress are known to be associated with headache." The new study included 53 veterans who had suffered a traumatic brain injury ... Read more

Related support groups: Migraine, Head Injury

Migraines Linked to Increased Risk of 'Silent Strokes'

Posted 16 May 2014 by Drugs.com

THURSDAY, May 15, 2014 – Older people who have migraines may be twice as likely to have "silent strokes," according to a new study. Silent strokes are symptomless brain injuries caused by a blood clot that disrupts blood flow to the brain. Researchers cautioned that these brain injuries are a risk factor for future strokes. "I do not believe migraine sufferers should worry, as the risk of ischemic stroke in people with migraine is considered small," the study's lead author, Dr. Teshamae Monteith, said in a news release from the American Heart Association. Monteith is an assistant professor of clinical neurology and chief of the headache division at the University of Miami Miller School of Medicine. "However, those with migraine and vascular risk factors may want to pay even greater attention to lifestyle changes that can reduce stroke risk, such as exercising and eating a low-fat diet ... Read more

Related support groups: Migraine, Ischemic Stroke, Transient Ischemic Attack

New Drugs May Help Prevent Migraines

Posted 22 Apr 2014 by Drugs.com

TUESDAY, April 22, 2014 – Two experimental drugs may help prevent migraines in people who suffer multiple attacks a month, according to preliminary findings from a pair of clinical trials. The drugs, one given by IV and one by injection, are part of a new approach to preventing migraine headaches. They are "monoclonal antibodies" that target a tiny protein called the calcitonin gene-related peptide (CGRP) – which recent research has implicated in triggering migraine pain. In one study, patients saw a 66 percent reduction in their migraine attacks five to eight weeks after a single dose of the IV drug – known for now as ALD403. That compared with a 52 percent decrease among patients who were given a placebo, or inactive, infusion. In the other trial, patients receiving the injection drug saw a similar benefit from three months' worth of biweekly treatments. The findings, scheduled to ... Read more

Related support groups: Migraine

Could Reducing Stress Help Bring On a Migraine?

Posted 1 Apr 2014 by Drugs.com

TUESDAY, April 1, 2014 – In a surprising twist on how stress may affect migraine risk, new research suggests that patients who are able to lower their stress levels may end up inadvertently boosting their immediate risk for a migraine attack. The study, led by Dr. Richard Lipton, director of the Montefiore Headache Center and vice chair of neurology at the Albert Einstein College of Medicine, in New York City, was published March 26 in the journal Neurology. "This study demonstrates a striking association between reduction in perceived stress and the occurrence of migraine headaches," Lipton said in a college news release. Though the authors noted that stress has long been seen as a trigger of headaches, the new study found that when migraine sufferers are able to relax following a bout of elevated stress, the stress decline itself may boost migraine risk. During the first six-hour ... Read more

Related support groups: Migraine

Topamax Approval for Migraines Expanded to Younger Users

Posted 31 Mar 2014 by Drugs.com

MONDAY, March 31, 2014 – U.S. Food and Drug Administration approval of the drug Topamax (topiramate) to prevent migraine headaches has been expanded to include adolescents 12 years to 17 years, the agency said Friday. It's the first migraine-prevention drug approved for adolescents, the FDA said in a news release. Topamax was first sanctioned in 1996 to prevent seizures, and was approved to prevent migraines in adults in 2004. Some 12 percent of the U.S. population has migraines, usually characterized by throbbing pain on one side of the head. Other symptoms may include nausea and sensitivity to light and sound. Topamax was evaluated in clinical studies involving 103 adolescent migraine sufferers. The most common side effects included burning or prickling sensations in the extremities, upper respiratory infection, loss of appetite and abdominal pain. The drug increases the risk of ... Read more

Related support groups: Migraine, Topamax, Migraine Prevention, Topiramate, Migraine Prophylaxis, Topamax Sprinkle, Topiragen

FDA Approves Topamax for Migraine Prevention in Adolescents

Posted 28 Mar 2014 by Drugs.com

March 28, 2014 – Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group. The medication is taken on a daily basis to reduce the frequency of migraine headaches. Topamax was first approved by the FDA in 1996 to prevent seizures. It was approved for migraine prevention in adults in 2004. “Migraine headaches can impact school performance, social interactions, and family life,” said Eric Bastings, M.D., deputy director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research. “Adding dosing and safety information for the adolescent age group to the drug’s prescribing information will help to inform health care professionals and patients in making treatment choices.” Abou ... Read more

Related support groups: Migraine, Topamax, Migraine Prevention, Topiramate, Migraine Prophylaxis

FDA Approves First Device to Prevent Migraines

Posted 11 Mar 2014 by Drugs.com

TUESDAY, March 11, 2014 – The U.S. Food and Drug Administration on Tuesday approved the first device aimed at preventing migraines. The device, called Cefaly, is a headband-like device that runs on a battery and sits across the forehead and over the ears, the FDA said in a statement. "The user positions the device in the center of the forehead, just above the eyes, using a self-adhesive electrode," the agency explained. "The device applies an electric current to the skin and underlying body tissues to stimulate branches of the trigeminal nerve, which has been associated with migraine headaches." Cefaly is made by Belgium-based Cefaly Technology and is available by prescription only. The device is only indicated for use by adults and should only be used for 20 minutes per day, the FDA said. The agency also noted that "the user may feel a tingling or massaging sensation where the ... Read more

Related support groups: Migraine

Power of Suggestion Revealed in Study of Migraine Drug

Posted 8 Jan 2014 by Drugs.com

WEDNESDAY, Jan. 8, 2014 – A new study of migraine sufferers suggests that what you're told when your doctor prescribes medication can influence your body's response to it. Researchers from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston compared the effects of a common migraine drug and an inactive placebo in 66 people who suffer from migraines. The condition includes throbbing headache, nausea, vomiting and sensitivity to light and sound. The results consistently showed that taking the pills accompanied by positive information increased the effectiveness of the treatment, whether the patient had taken the real deal – the drug Maxalt – or a pill labeled "placebo." Headache specialist Dr. Andrew Charles said the study demonstrates that expectation about response plays an important role in the ultimate response to a treatment. "When migraine patients were told ... Read more

Related support groups: Migraine, Maxalt, Maxalt-MLT, Rizatriptan

Behavioral Therapy Might Ease Kids' Migraine Symptoms

Posted 26 Dec 2013 by Drugs.com

TUESDAY, Dec. 24, 2013 – A specific type of therapy helps reduce the number of migraines and migraine-related disabilities in children and teens, according to a new study. The findings provide strong evidence for the use of "cognitive behavioral therapy" – which includes training in coping with pain – in managing chronic migraines in children and teens, said study leader Scott Powers, of Cincinnati Children's Hospital Medical Center, and colleagues. The therapy should be routinely offered as a first-line treatment, along with medications, he said. More than 2 percent of adults and about 1.75 percent of children have chronic migraines, according to the study, which was published in the Dec. 25 issue of the Journal of the American Medical Association. But there are no treatments approved by the U.S. Food and Drug Administration to quell these debilitating headaches in young people, the ... Read more

Related support groups: Migraine

FDA Approves New Magnet Device to Treat Migraines

Posted 16 Dec 2013 by Drugs.com

SUNDAY, Dec. 15, 2013 – The U.S. Food and Drug Administration has approved the first device aimed at easing the pain of migraines preceded by aura – sensory disturbances that occur just before an attack. About a third of migraine sufferers experience auras. The Cerena Transcranial Magnetic Stimulator would be obtained through prescription, the FDA said in a statement released Friday. Patients use both hands to hold the device against the back of their head and press a button so that the device can release a pulse of magnetic energy. This pulse stimulates the brain's occipital cortex, which may stop or ease migraine pain. "Millions of people suffer from migraines, and this new device represents a new treatment option for some patients," Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said in the statement. The ... Read more

Related support groups: Migraine

First Device to Treat Migraine With Aura Approved

Posted 16 Dec 2013 by Drugs.com

MONDAY, Dec. 16, 2013 – The first device to treat migraine pain when the headache is preceded by an often-visual disturbance called an aura has been approved by the U.S. Food and Drug Administration. The Cerena Transcranial Magnetic Stimulator (TMS) is held to the back of the head and the user presses a button to release a pulse of magnetic energy. This stimulates the brain's occipital cortex, which may reduce or eliminate migraine-associated pain, the FDA said in a news release. The device was tested in a clinical trial of 201 people with mostly moderate-to-strong migraines. Nearly 38 percent of people with migraine pain were pain-free two hours after use, compared with 17 percent of people who didn't use the device, the FDA said. The device was not evaluated among people with headaches other than those with migraines preceded by aura, the agency said. Among the rare side effects ... Read more

Related support groups: Migraine

Nasal Allergies, Hay Fever Tied to More Migraines in Study

Posted 26 Nov 2013 by Drugs.com

TUESDAY, Nov. 26, 2013 – Allergies and hay fever may increase the number and severity of migraine headaches, according to a new study. Researchers analyzed data from nearly 6,000 migraine sufferers who filled out a questionnaire in 2008 as part of the American Migraine Prevalence and Prevention Study. Two-thirds of the respondents said they had nasal or seasonal allergies, or hay fever. Based on the findings, the study authors concluded that those with allergies and hay fever were 33 percent more likely to have more frequent migraines than those without these conditions. The report was published online Nov. 25 in the journal Cephalalgia. The study is one of the first to link the frequency of migraines to irritation and inflammation of the nasal mucus membrane caused by allergic and non-allergic triggers, according to lead author Dr. Vincent Martin. He is a professor of medicine at the ... Read more

Related support groups: Migraine, Allergies, Allergic Rhinitis, Hay Fever

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Migraine Prevention, Migraine Prophylaxis, Trochleitis, Headache

Related Drug Support Groups

gabapentin, cyclobenzaprine, diclofenac, Botox, Imitrex, Excedrin, Reglan, Maxalt, sumatriptan, view more... Periactin, metoclopramide, cyproheptadine, Fiorinal, Norflex, Zomig, orphenadrine, Relpax, Cafergot, Excedrin Migraine, Treximet, Vioxx, ergotamine, memantine, Maxalt-MLT, Frova, Migranal, Cambia, Migergot, Amerge, Excedrin Extra Strength, feverfew, rizatriptan, Levacet, zolmitriptan, Methergine, dihydroergotamine, Butalbital Compound, Sansert, DHE 45, aspirin/butalbital/caffeine, almotriptan, Vanquish, Painaid, methysergide maleate, naratriptan, Maxolon, Imitrex Statdose, Goodys Extra Strength, Fortabs, Sumavel DosePro, Zomig-ZMT, Flexon, Fiortal, Ergomar, methylergonovine, Axert, onabotulinumtoxina, Wigraine, Ergocomp-PB, Cafetrate, ErgocaffPB, Ergocaf-PB, E-Caff P-B, Ercaf, Migracet-PB, rofecoxib, Alsuma, acetaminophen/aspirin/caffeine/salicylamide, Exaprin, Zecuity, belladonna/caffeine/ergotamine/pentobarbital, caffeine/ergotamine, Micomp-PB, frovatriptan, eletriptan, Cafatine, Belcomp-PB, Orphenate, Imitrex Nasal, Saleto, Goodys Headache Powders, Antiflex, Norflex Injectable, Mio-Rel, Myolin, Orfro, Genace, Supac, Idenal, Laniroif, Flexoject, naproxen/sumatriptan, Fiormor, Banflex, acetaminophen/aspirin/caffeine, Farbital, Cafatine PB